Beraprost-314d crystals and methods for preparation thereof
A technology of beraprost and -314d, which is applied in the fields of organic chemistry methods, drug combinations, cardiovascular system diseases, etc., can solve the uncertain whether there is crystal form I transformation of beraprost-314d, unrevealed beraprost - 314d crystal form I stability data, unable to evaluate, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example
[0068] X-Ray Powder Diffraction (XRPD) Analysis: XRPD patterns were collected on a Bruker D2 PHASER diffractometer with fixed divergence slit and ID LYNXEYE detector. The sample (approximately 100 mg) was placed flat on the sample holder. Use CuK α Radiation The as-prepared samples were analyzed at an energy of 10 mA and 30 kV over a 2Θ range of 5° to 50° with a step size of 0.02 degrees and a step time of 1 second. Removal of CuK by Diverging Beam Nickel Filter β radiation.
[0069] Differential Scanning Calorimetry (DSC) Analysis: DSC traces were collected on a TA DISCOVERY DSC25 instrument. Samples (approximately 5 mg) were weighed into aluminum pans with crimped closed aluminum lids. The prepared samples were analyzed from 10°C to 100°C at a scan rate of 10°C / min under nitrogen flow (approximately 50ml / min). The melting temperature and heat of fusion were calibrated by indium (In) before measurement.
example 1
[0071] Preparation of Crude Beraprost-314d
[0072] 2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-1H-cyclopenta[b]benzofuran- 5-Butyric acid methyl ester (50.0 g, 121.2 mmol) was dissolved in 200 ml of methanol, followed by the addition of 200 ml of 1 N sodium hydroxide / water solution and stirred for 2 hours. The reaction mixture was separated by acid-base extraction, and the solvent was evaporated under vacuum. The crude product was purified by silica gel chromatography using a mixture of hexane and ethyl acetate as gradient eluent to obtain 33.2 g of crude Beraprost-314d.
example 2
[0074] Preparation of Beraprost-314d Crystalline Form II
[0075]Crude beraprost-314d (1.00 g from Example 1) and ethyl acetate (10 ml) were heated to 40°C to dissolve and then cooled to room temperature. n-Hexane (20 ml) was slowly added dropwise, and the mixture was stirred in an ice-water bath for 18 hours until solid precipitation occurred. Afterwards, the resulting suspension was filtered and washed, followed by drying under high vacuum at room temperature for 24 hours, yielding 0.75 g of Beraprost-314d crystalline Form II. XRPD and DSC results with figure 1 and figure 2 same as shown in .
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



